Home Investors News Press Releases 2009

If you would like to be alerted when a press release is added to this site, please register with the Alerting Service.

Select a month	AllJanuary February March April May June July August September October November December
Select a year	All2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997
Search for:

12/30/2009	Cyclacel announces publication of peer-reviewed journal article describing the mechanism of action of seliciclib
12/15/2009	Cyclacel receives NASDAQ notice of non-compliance
12/15/2009	Cyclacel provides update on meeting with FDA to discuss pivotal study design for sapacitabine
12/05/2009	Cyclacel reports Phase 2 sapacitabine data in acute myeloid leukemia and myelodysplastic syndromes at 2009 ASH annual meeting
12/01/2009	Cyclacel to host conference call on Monday, December 7 to discuss new Phase 2 sapacitabine data to be presented at ASH
11/30/2009	Sapacitabine phase 1 data published in acute leukemia and myelodysplastic syndromes
11/17/2009	Cyclacel Pharmaceuticals to present Sapacitabine Phase 2 AML & MDS data at the upcoming American Society of Hematology meeting
11/03/2009	Cyclacel Announces Third Quarter 2009 Financial Results
10/30/2009	Cyclacel Receives Deficiency Notice From Nasdaq Global Select Market
10/28/2009	Cyclacel reports survival data from phase 2 sapacitabine study in elderly patients with acute myeloid leukemia
1  2  3  4    >>

  Go to top      Print page